» Articles » PMID: 6951491

Aspects of the Natural History of Myasthenia Gravis: Crisis and Death

Overview
Specialty Science
Date 1981 Jan 1
PMID 6951491
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

In an analysis of myasthenia crises during the past 20 years, the incidence of crisis remained fairly constant at 12-16%, but the fatality rate of crises declined from 42% to 6%, and the overall mortality of myasthenia declined from 12% to 3.3%. Most crisis episodes were caused by aspiration pneumonia or occurred in patients with severe dysphagia, who were at risk of aspiration. Cholinergic drug therapy clearly was not useful during crisis, and should probably be discontinued while the patient is on a respirator. Fifteen of 28 patients with thymectomy had 21 episodes of crisis months or years after surgery. Ultimately, 42% of crisis survivors achieved a state of improved myasthenia or remission after one or more crises.

Citing Articles

Myasthenia gravis in 2025: five new things and four hopes for the future.

Binks S, Morse I, Ashraghi M, Vincent A, Waters P, Leite M J Neurol. 2025; 272(3):226.

PMID: 39987373 PMC: 11846739. DOI: 10.1007/s00415-025-12922-7.


Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion.

Mantegazza R, Sacca F, Antonini G, Bonifati D, Evoli A, Habetswallner F Neurol Sci. 2024; 45(12):5671-5683.

PMID: 38967883 DOI: 10.1007/s10072-024-07577-7.


Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study.

Wang Y, Huan X, Zhu X, Song J, Yan C, Yang L Ther Adv Neurol Disord. 2024; 17:17562864241226745.

PMID: 38344193 PMC: 10858673. DOI: 10.1177/17562864241226745.


A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis.

Harris L, Graham S, MacLachlan S, Exuzides A, Jacob S BMC Neurol. 2022; 22(1):172.

PMID: 35534810 PMC: 9082838. DOI: 10.1186/s12883-022-02692-4.


Patients With Myasthenia Gravis With Acute Onset of Dyspnea: Predictors of Progression to Myasthenic Crisis and Prognosis.

Huang Y, Tan Y, Shi J, Li K, Yan J, Guan Y Front Neurol. 2021; 12:767961.

PMID: 34867753 PMC: 8637205. DOI: 10.3389/fneur.2021.767961.